Emrg Mkts ETF MSCI Vanguard (VWO) 40.87 $VWO Setting Up

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Emrg Mkts ETF MSCI Vanguard (VWO) 40.87 $VWO

Setting Up And Running Your Dividend Growth Investment Plan Like A Business
On2Freedom - at Seeking Alpha - Tue Mar 31, 2:27PM CDT

KO: 40.55 (+0.04), JNJ: 100.60 (-0.95), BAX: 68.50 (-0.26), AZN: 68.43 (-1.51), VIG: 80.47 (-0.77), VWO: 40.87 (-0.03), PG: 81.94 (-0.78), PEP: 95.62 (-0.90)

KISS Retirement Portfolio: My Retirement Portfolio
Robert Mattei - at Seeking Alpha - Tue Mar 31, 2:17PM CDT

VTV: 83.70 (-0.46), IJR: 118.03 (-0.46), VEA: 39.83 (-0.57), IWN: 103.21 (-0.25), IEFA: 58.49 (-0.89), SCHA: 57.58 (-0.23), IXUS: 55.40 (-0.59), SCHB: 50.48 (-0.38), SCHE: 24.36 (-0.08), TLT: 130.69 (+0.28), IUSB: 102.75 (+0.19), VTI: 107.25 (-0.98), SCHH: 40.55 (-0.40), VB: 122.56 (-0.01), SPY: 206.43 (-1.82), VBR: 109.40 (-0.21), SCHP: 54.92 (+0.14), IVE: 92.56 (-0.66), SCHR: 54.36 (+0.09), VNQ: 84.31 (-0.75), VXUS: 50.35 (-0.53), SCHV: 43.27 (-0.32), VGIT: 65.42 (+0.13), TIP: 113.59 (+0.26), SCHZ: 52.91 (+0.06), IEI: 124.17 (+0.23), EDV: 129.81 (+0.43), RWR: 94.57 (-0.87), VTIP: 48.46 (+0.06), VOO: 189.20 (-1.68), VWO: 40.87 (-0.03), EFA: 64.17 (-1.01), BND: 83.37 (+0.09), IEMG: 48.33 (-0.15)

Watch for Vanguard Emerging Markets ETF to Potentially Pullback After Gaining 2.05% Yesterday
Comtex SmarTrend(R) - Mon Mar 30, 4:06PM CDT
Vanguard Emerging Markets ETF (AMEX:VWO) traded in a range yesterday that spanned from a low of $40.46 to a high of $41.01. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $40.94 on volume of 8.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VWO: 40.87 (-0.03)

SmarTrend Watching for Potential Pullback in Shares of Vanguard Emerging Markets ETF After 2.05% Gain
Comtex SmarTrend(R) - Mon Mar 30, 4:06PM CDT
Vanguard Emerging Markets ETF (AMEX:VWO) traded in a range yesterday that spanned from a low of $40.46 to a high of $41.01. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $40.94 on volume of 8.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VWO: 40.87 (-0.03)

A Commission Free Portfolio That Can Beat The Market
Brian Burns - at Seeking Alpha - Sun Mar 29, 4:07AM CDT

TIP: 113.59 (+0.26), VB: 122.56 (-0.01), VEA: 39.83 (-0.57), VO: 132.70 (+3.12), IWN: 103.21 (-0.25), VYM: 68.30 (-0.28), VWO: 40.87 (-0.03), VPU: 96.88 (+0.04), BLV: 96.32 (+0.12), VNQ: 84.31 (-0.75), MGK: 83.34 (-0.79)

ILF, VWO, APH, SIG, LFC, AMOV Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Mar 26, 12:11PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Ishares S & P Latin America 40 (NYSE:ILF), Vanguard MSCI Emerging Markets Fund ETF (NYSE:VWO), AMPHENOL CORPORATION (NYSE:APH), Signet Jewelers Ltd (NYSE:SIG), China Life Insurance Co Ltd (NYSE:LFC), America Movil SAB de CV (NASDAQ:AMOV) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
APH: 58.93 (+0.16), LFC: 66.08 (-1.16), VWO: 40.87 (-0.03), AMOV: 20.32 (-0.20), ILF: 29.35 (+0.08), SIG: 138.79 (-0.99)

Vanguard Emerging Markets ETF Falls 1.90% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Mar 25, 4:26PM CDT
Vanguard Emerging Markets ETF (AMEX:VWO) traded in a range yesterday that spanned from a low of $40.22 to a high of $40.94. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $40.57 on volume of 12.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VWO: 40.87 (-0.03)

Vanguard Emerging Markets ETF Set to Possibly Rebound After Yesterday's Selloff of 1.90%
Comtex SmarTrend(R) - Wed Mar 25, 4:26PM CDT
Vanguard Emerging Markets ETF (AMEX:VWO) traded in a range yesterday that spanned from a low of $40.22 to a high of $40.94. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $40.57 on volume of 12.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VWO: 40.87 (-0.03)

Vanguard FTSE Emerging Markets ETF announces quarterly distribution of $0.071
Seeking Alpha - at Seeking Alpha - Tue Mar 24, 1:11PM CDT

VWO: 40.87 (-0.03)

Combining Dividend Aristocrats And ETFs For A Retirement Portfolio
Lowell Herr - at Seeking Alpha - Mon Mar 23, 8:12PM CDT

VTI: 107.25 (-0.98), BIV: 86.21 (+0.14), CINF: 53.28 (-0.35), VEA: 39.83 (-0.57), RWX: 43.32 (-0.48), LEG: 46.09 (+0.10), TGT: 82.07 (-0.07), SHY: 84.88 (+0.07), VWO: 40.87 (-0.03), VNQ: 84.31 (-0.75), TLT: 130.69 (+0.28)

2 ETF Winners And A Loser Post Fed Meeting
Zacks Funds - at Seeking Alpha - Sun Mar 22, 9:29PM CDT
The latest Fed meeting was presumably the most anticipated one in quite some time, as investors increasingly wagered on a June timeline for the first rate hike after 2006. However, the Fed had a dovish and soothing session yet again. Though the Fed...
VWO: 40.87 (-0.03), GDX: 18.24 (-0.23), UUP: 25.90 (+0.04)

Inside My Portfolio: What I Hold And Why
ColoradoWealthManagementFund - at Seeking Alpha - Sun Mar 22, 5:46AM CDT

VTI: 107.25 (-0.98), SOL: 1.47 (+0.02), ANH: 5.09 (-0.02), FCX: 18.95 (-0.43), VWO: 40.87 (-0.03), WMC: 15.08 (-0.10), VNQ: 84.31 (-0.75), DX: 8.47 (+0.02)

Portfolio Construction Using Asset Allocation, Momentum And Efficient Frontier Analysis
Lowell Herr - at Seeking Alpha - Sun Mar 22, 2:05AM CDT

VTI: 107.25 (-0.98), VUG: 104.61 (-3.93), DBC: 17.07 (-0.20), VEA: 39.83 (-0.57), GLD: 113.66 (-0.09), SHY: 84.88 (+0.07), VWO: 40.87 (-0.03)

FOMC: Connecting The Dots
Enzio von Pfeil - Seeking Alpha - Sat Mar 21, 7:32AM CDT
Forget demand-driven inflation; worry about debt inflation in the Submerging Markets Dot plots. We won't bother re-phrasing the Financial Times' (FT's): "In the hours after the Fed's statement was released, its 'dot plot' setting out...
EMFT: 46.89 (unch), EMLB: 85.00 (unch), EWEM: 32.21 (unch), EDZ: 33.16 (+0.31), EMSA: 65.54 (unch), EMCR: 20.40 (+0.28), EET: 69.58 (-0.52), EEV: 18.34 (+0.10), DBEM: 22.16 (-0.10), SCHE: 24.36 (-0.08), XSOE: 25.13 (-0.01), EUM: 25.46 (+0.06), EEME: 43.30 (-0.02), EEM: 40.13 (-0.09), ADRE: 34.80 (-0.05), HEEM: 24.48 (-0.11), FEM: 22.19 (-0.11), VWO: 40.87 (-0.03), EDC: 23.69 (-0.16), IEMG: 48.33 (-0.15), GMM: 64.22 (-0.28)

The Zacks Analyst Blog Highlights: PowerShares DB US Dollar Bullish Fund, Market Vectors Gold Miners ETF and Vanguard Emerging Markets ETFs - Press Releases
Zacks Equity Research - Zacks Investment Research - Fri Mar 20, 8:30AM CDT
The Zacks Analyst Blog Highlights: PowerShares DB US Dollar Bullish Fund, Market Vectors Gold Miners ETF and Vanguard Emerging Markets ETFs
VWO: 40.87 (-0.03), GDX: 18.24 (-0.23), UUP: 25.90 (+0.04)

2 ETF Winners and a Loser Post Fed Meeting - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 12:02PM CDT
These ETFs saw big moves after the Fed rate forecast and comments about the timeline of first rate hike.
AAXJ: 64.00 (-0.32), GLD: 113.66 (-0.09), VWO: 40.87 (-0.03), GDX: 18.24 (-0.23), UUP: 25.90 (+0.04)

Emerging markets give back some post-FOMC gains
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 10:23AM CDT

EMFT: 46.89 (unch), EMLB: 85.00 (unch), EWEM: 32.21 (unch), EDZ: 33.16 (+0.31), EMSA: 65.54 (unch), EMCR: 20.40 (+0.28), EET: 69.58 (-0.52), EEV: 18.34 (+0.10), DBEM: 22.16 (-0.10), SCHE: 24.36 (-0.08), XSOE: 25.13 (-0.01), EUM: 25.46 (+0.06), EEME: 43.30 (-0.02), EEM: 40.13 (-0.09), ADRE: 34.80 (-0.05), HEEM: 24.48 (-0.11), FEM: 22.19 (-0.11), RSX: 17.03 (-0.21), VWO: 40.87 (-0.03), EDC: 23.69 (-0.16), EWZ: 31.37 (+0.28), GMM: 64.22 (-0.28), IEMG: 48.33 (-0.15)

March Madness: Final 4 Investing Bracket 2015
Matthew Pixa - Seeking Alpha - Thu Mar 19, 6:18AM CDT
Welcome to the fifth year of our March Madness Investing Bracket! This series of articles is always one of the most popular investing articles on the internet! We're proud to admit that we were one of the first investing nerds to combine our love for...
WFM: 52.08 (-0.27), KR: 76.66 (-0.58), NOC: 160.96 (-1.72), VO: 132.70 (+3.12), SMG: 67.17 (+0.90), WMT: 82.25 (-0.28), COP: 62.26 (-1.74), GSK: 46.15 (-1.05), IVV: 207.83 (-1.79), INTC: 31.27 (-0.19), EVOL: 8.82 (unch), VB: 122.56 (-0.01), SCS: 18.94 (+0.01), GLD: 113.66 (-0.09), TGT: 82.07 (-0.07), EPI: 22.80 (+0.02), RSX: 17.03 (-0.21), VWO: 40.87 (-0.03), SIX: 48.41 (+0.10), MSFT: 40.65 (-0.31), VNQ: 84.31 (-0.75), AAPL: 124.43 (-1.94), DBV: 24.81 (unch), OMI: 33.84 (-0.58)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Man Group PLC Highlights Its Strategic Disclosures on Tritax REIT

Updated Category News Views 148

Strategic Position Disclosure by Man Group PLC Man Group PLC is actively sharing its significant interests in the securities market, particularly focusing on its involvement with Tritax Big Box REIT plc. As a key player in the investment landscape, this disclosure marks an important step for the company regarding its strategic holdings. Key Information Pertaining to the...

Continue Reading
TalentLMS and Epignosis Lead the Way in GDPR Compliance

Updated Category News Views 720

TalentLMS and Epignosis Set the Standard for GDPR Compliance TalentLMS, along with its parent company Epignosis, has continuously led the way in providing a fully compliant Learning Management System (LMS) with regards to the General Data Protection Regulation (GDPR). Recent developments affirm that TalentLMS remains the only LMS globally to uphold its commitment to this...

Continue Reading
Zillow and Esusu Forge New Path to Boost Renters' Credit Scores

Updated Category News Views 283

Building Credit for Renters with Zillow and Esusu The recent collaboration between Zillow and Esusu marks a significant step towards empowering renters across the country to build their credit. This partnership allows any renter to report their on-time rent payments, significantly enhancing their credit profiles, for just $20 a year. How the Partnership Works Starting...

Continue Reading
iCrowdNewswire Leverages DeepL for Enhanced Global Communication

Updated Category News Views 121

iCrowdNewswire Enhances Multilingual Capabilities iCrowdNewswire, a prominent international press release distribution company, has embarked on a transformative journey to improve its multilingual services through the introduction of the DeepL API. The integration of DeepL's cutting-edge language AI technology has significantly boosted iCrowdNewswire’s ability to...

Continue Reading
Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Updated Category News Views 82

Exceptional Recognition for Leading Surgeons in Endocrine Surgery Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable...

Continue Reading